Defining Volume Status in Sepsis With Extracellular Water Measurement
Phenotypes in Sepsis - Extracellular Water for Volume Status Characterization
1 other identifier
observational
20
1 country
1
Brief Summary
The goal of this observational study is to learn about the influence of extracellular water on volume status in adult sepsis patients presenting with hemodynamic instability. The main question it aims to answer is: • Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients. Patients with sepsis admitted to intensive care will receive standard care with the addition of measurement of extracellular water.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 14, 2026
March 1, 2025
2.8 years
July 15, 2024
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Phenotypes in sepsis - extracellular water for volume status characterization.
Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients during the first 72 hours?
7 days
Eligibility Criteria
Adult patients admitted to an ICU in Uppsala with suspected or confirmed sepsis.
You may qualify if:
- Adults with sepsis.
You may not qualify if:
- Pregnancy, other than sepsis known cause of shock.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AnOpIva
Uppsala, Uppsa, 75309, Sweden
Related Publications (3)
Nuutinen J, Ikaheimo R, Lahtinen T. Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat. Physiol Meas. 2004 Apr;25(2):447-54. doi: 10.1088/0967-3334/25/2/004.
PMID: 15132310BACKGROUNDToro C, Markarian B, Mayrovitz HN. Breast Cancer-Related Lymphedema Assessed via Tissue Dielectric Constant Measurements. Cureus. 2024 Apr 29;16(4):e59261. doi: 10.7759/cureus.59261. eCollection 2024 Apr.
PMID: 38813316BACKGROUNDDe Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tascon GA, Ostermann M, Pinsky MR, Vincent JL. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022 Dec 1;26(1):372. doi: 10.1186/s13054-022-04255-y.
PMID: 36457089BACKGROUND
Biospecimen
Blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annelie Barrueta Tenhunen, MD, PhD
Uppsala University, Region Uppsala
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2024
First Posted
July 22, 2024
Study Start
March 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
January 14, 2026
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
The data will only be accessible to the research team.